Displaying 1–2 of 2 results for Don Gerson, President, Axenic, Inc
Global efforts driving safer syringes for developing nations are spurring interest in new single-use, auto-disable syringes. Parenterals manufacturers should be prepared and evaluate the new designs with new products.
Its U.K. vaccine plant has been a nightmare. Could better risk management, due diligence, regulatory oversight or new technology have led to a different outcome?